Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Mari Iida, Toni M. Brand, Megan M. Starr, Evan J. Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler · 2025
Read Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy by Mari Iida, Toni M. Brand, Megan M. Starr, Evan J. Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12752348.txt.
Description
R, EGFR, pMAPK, MAPK, and α-tubulin were inadvertently sourced from a previous publication. After working closely with the editorial team, the authors have now provided the correct blots for Figure 1A. This correction does not impact the findings or conclusions of the article.
Catalog record
| CREATOR | Mari Iida, Toni M. Brand, Megan M. Starr, Evan J. Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |